Sofinnova Investments, Inc. Quant / Systematic

Location: Menlo Park, CA

CIK: 0001631134 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $1.934B (100.0% shares, 0.0% debt)

Holdings (57)

New Positions (13)

SPTX Seaport Therapeutics Inc 4.0%
Value $77.43M Shares 3,564,871 Share Price $21.72 Est. Cost/Share — Unrealized @ Report Date —
GILD Gilead Sciences Inc 2.2%
Value $43.35M Shares 343,100 Share Price $126.34 Est. Cost/Share — Unrealized @ Report Date —
ISRG Intuitive Surgical Inc 0.8%
Value $15.91M Shares 40,000 Share Price $397.68 Est. Cost/Share — Unrealized @ Report Date —
GMED Globus Med Inc 0.8%
Value $15.8M Shares 200,000 Share Price $79.01 Est. Cost/Share — Unrealized @ Report Date —
NRIX Nurix Therapeutics Inc 0.7%
Value $12.71M Shares 524,098 Share Price $24.26 Est. Cost/Share — Unrealized @ Report Date —
DSGN Design Therapeutics Inc 0.6%
Value $12.52M Shares 865,135 Share Price $14.47 Est. Cost/Share — Unrealized @ Report Date —
TRAX First Tracks Biotherapeutics 0.6%
Value $11.37M Shares 565,199 Share Price $20.12 Est. Cost/Share — Unrealized @ Report Date —
ABT Abbott Laboratories 0.6%
Value $11.16M Shares 122,998 Share Price $90.74 Est. Cost/Share — Unrealized @ Report Date —
SION Sionna Therapeutics Inc 0.3%
Value $6.354M Shares 144,432 Share Price $43.99 Est. Cost/Share — Unrealized @ Report Date —
ABSI Absci Corporation 0.2%
Value $3.91M Shares 337,400 Share Price $11.59 Est. Cost/Share — Unrealized @ Report Date —
SGMT Sagimet Biosciences Inc 0.1%
Value $1.288M Shares 166,667 Share Price $7.73 Est. Cost/Share — Unrealized @ Report Date —
AKTS Aktis Oncology Inc 0.1%
Value $1.045M Shares 32,436 Share Price $32.23 Est. Cost/Share — Unrealized @ Report Date —
HTFL Heartflow Inc 0.0%
Value $149K Shares 5,079 Share Price $29.34 Est. Cost/Share — Unrealized @ Report Date —

Increased Positions (14)

GMAB Genmab A/S 5.7%
Value $111M (+450.6%) Shares 4,045,215 (+437.7%) Share Price $27.47 Est. Cost/Share — Unrealized @ Report Date —
ANAB Anaptysbio Inc 1.7%
Value $33.31M (+142.0%) Shares 493,536 (+98.8%) Share Price $67.50 Est. Cost/Share — Unrealized @ Report Date —
MANE Veradermics Inc 0.9%
Value $18.32M (+295.6%) Shares 148,993 (+103.2%) Share Price $122.94 Est. Cost/Share — Unrealized @ Report Date —
RARE Ultragenyx Pharmaceutical In 0.9%
Value $16.7M (+127.7%) Shares 500,000 (+42.9%) Share Price $33.39 Est. Cost/Share — Unrealized @ Report Date —
RCUS Arcus Biosciences Inc 1.5%
Value $29.16M (+46.2%) Shares 945,690 (+2.4%) Share Price $30.83 Est. Cost/Share — Unrealized @ Report Date —
PHVS Pharvaris N V 1.6%
Value $30.48M (+31.8%) Shares 881,299 (+7.7%) Share Price $34.58 Est. Cost/Share — Unrealized @ Report Date —
DYN Dyne Therapeutics Inc 1.9%
Value $36.83M (+24.3%) Shares 1,658,384 (+1.5%) Share Price $22.21 Est. Cost/Share — Unrealized @ Report Date —
IRON Disc Medicine Inc 0.6%
Value $10.7M (+113.6%) Shares 146,239 (+86.7%) Share Price $73.14 Est. Cost/Share — Unrealized @ Report Date —
TENX Tenax Therapeutics Inc 0.4%
Value $7.276M (+335.8%) Shares 500,039 (+379.0%) Share Price $14.55 Est. Cost/Share — Unrealized @ Report Date —
EXEL Exelixis Inc 0.7%
Value $13.83M (+28.2%) Shares 254,200 (+1.1%) Share Price $54.41 Est. Cost/Share — Unrealized @ Report Date —
IMTX Immatics N.V 1.9%
Value $37.17M (+4.0%) Shares 3,669,346 (+1.1%) Share Price $10.13 Est. Cost/Share — Unrealized @ Report Date —
SUPN Supernus Pharmaceuticals 2.5%
Value $48.2M (-2.3%) Shares 1,036,328 (+8.6%) Share Price $46.51 Est. Cost/Share — Unrealized @ Report Date —
OKUR Onkure Therapeutics Inc 0.1%
Value $1.467M (+150.1%) Shares 321,692 (+127.0%) Share Price $4.56 Est. Cost/Share — Unrealized @ Report Date —
IMNM Immunome Inc 1.9%
Value $36.45M (-2.1%) Shares 1,720,316 (+1.1%) Share Price $21.19 Est. Cost/Share — Unrealized @ Report Date —

Exited Positions (30)

IWM iShares TR 7.7%
Value $149M Shares 600,000 Share Price $248.00 Est. Cost/Share — Unrealized @ Report Date —
XBI SPDR Series Trust 6.9%
Value $134M Shares 1,050,000 Share Price $127.73 Est. Cost/Share — Unrealized @ Report Date —
AZN AstraZeneca PLC 4.6%
Value $89.94M Shares 456,031 Share Price $197.22 Est. Cost/Share — Unrealized @ Report Date —
QQQ Invesco QQQ TR 4.5%
Value $86.58M Shares 150,000 Share Price $577.18 Est. Cost/Share — Unrealized @ Report Date —
IBB iShares TR 4.1%
Value $80.2M Shares 475,000 Share Price $168.85 Est. Cost/Share — Unrealized @ Report Date —
UTHR United Therapeutics Corp 2.5%
Value $47.62M Shares 80,300 Share Price $592.98 Est. Cost/Share — Unrealized @ Report Date —
BIIB Biogen Inc 2.2%
Value $42.08M Shares 229,521 Share Price $183.33 Est. Cost/Share — Unrealized @ Report Date —
CELC Celcuity Inc 2.2%
Value $41.8M Shares 366,175 Share Price $114.14 Est. Cost/Share — Unrealized @ Report Date —
CELC Celcuity Inc 1.8%
Value $34.24M Shares 300,000 Share Price $114.14 Est. Cost/Share — Unrealized @ Report Date —
AXSM Axsome Therapeutics Inc. 1.7%
Value $33.8M Shares 200,000 Share Price $169.02 Est. Cost/Share — Unrealized @ Report Date —
BBIO BridgeBio Pharma Inc 1.6%
Value $30.39M Shares 409,183 Share Price $74.26 Est. Cost/Share — Unrealized @ Report Date —
DXCM Dexcom Inc 1.3%
Value $24.72M Shares 393,576 Share Price $62.80 Est. Cost/Share — Unrealized @ Report Date —
PFE Pfizer Inc 1.2%
Value $22.46M Shares 800,000 Share Price $28.08 Est. Cost/Share — Unrealized @ Report Date —
LQDA Liquidia Corporation 1.0%
Value $18.87M Shares 500,000 Share Price $37.74 Est. Cost/Share — Unrealized @ Report Date —
XENE Xenon Pharmaceuticals Inc 0.9%
Value $17.75M Shares 305,216 Share Price $58.15 Est. Cost/Share — Unrealized @ Report Date —
SYK Stryker Corporation 0.8%
Value $14.62M Shares 44,480 Share Price $328.59 Est. Cost/Share — Unrealized @ Report Date —
ROIV Roivant Sciences Ltd 0.7%
Value $13.24M Shares 477,995 Share Price $27.70 Est. Cost/Share — Unrealized @ Report Date —
CMPX Compass Therapeutics Inc 0.6%
Value $10.88M Shares 2,056,161 Share Price $5.29 Est. Cost/Share — Unrealized @ Report Date —
ORIC Oric Pharmaceuticals Inc 0.4%
Value $8.61M Shares 679,578 Share Price $12.67 Est. Cost/Share — Unrealized @ Report Date —
TNGX Tango Therapeutics Inc 0.4%
Value $8.265M Shares 395,081 Share Price $20.92 Est. Cost/Share — Unrealized @ Report Date —
REPL Replimune Group Inc 0.4%
Value $7.768M Shares 1,015,400 Share Price $7.65 Est. Cost/Share — Unrealized @ Report Date —
AXGN AxoGen Inc 0.4%
Value $6.979M Shares 210,665 Share Price $33.13 Est. Cost/Share — Unrealized @ Report Date —
CYTK Cytokinetics Inc 0.3%
Value $6.05M Shares 91,791 Share Price $65.91 Est. Cost/Share — Unrealized @ Report Date —
HRMY Harmony Biosciences Hldgs Inc 0.2%
Value $4.277M Shares 152,695 Share Price $28.01 Est. Cost/Share — Unrealized @ Report Date —
PCVX Vaxcyte Inc 0.2%
Value $2.94M Shares 50,600 Share Price $58.11 Est. Cost/Share — Unrealized @ Report Date —
CMPX Compass Therapeutics Inc 0.1%
Value $2.645M Shares 500,000 Share Price $5.29 Est. Cost/Share — Unrealized @ Report Date —
ESTA Establishment Labs Hldgs Inc 0.1%
Value $1.927M Shares 33,930 Share Price $56.78 Est. Cost/Share — Unrealized @ Report Date —
ACAD Acadia Pharmaceuticals Inc 0.1%
Value $1.749M Shares 78,551 Share Price $22.26 Est. Cost/Share — Unrealized @ Report Date —
SLNO Soleno Therapeutics Inc 0.0%
Value $492K Shares 14,689 Share Price $33.48 Est. Cost/Share — Unrealized @ Report Date —
ZYME Zymeworks Inc 0.0%
Value $40,314 Shares 1,610 Share Price $25.04 Est. Cost/Share — Unrealized @ Report Date —

Decreased Positions (17)

BMY Bristol-Myers Squibb Co 2.6%
Value $50.53M (-58.1%) Shares 876,970 (-55.9%) Share Price $57.62 Est. Cost/Share — Unrealized @ Report Date —
UTHR United Therapeutics Corp Del 2.1%
Value $41.44M (-56.3%) Shares 76,489 (-52.2%) Share Price $541.83 Est. Cost/Share — Unrealized @ Report Date —
COGT Cogent Biosciences Inc 2.1%
Value $40.06M (-50.8%) Shares 1,035,148 (-51.0%) Share Price $38.70 Est. Cost/Share — Unrealized @ Report Date —
INSM Insmed Inc 0.9%
Value $16.89M (-70.2%) Shares 158,398 (-54.2%) Share Price $106.62 Est. Cost/Share — Unrealized @ Report Date —
ALC Alcon AG 0.9%
Value $17.17M (-68.8%) Shares 255,824 (-65.0%) Share Price $67.10 Est. Cost/Share — Unrealized @ Report Date —
JAZZ Jazz Pharmaceuticals PLC 4.6%
Value $88.04M (-22.2%) Shares 365,341 (-38.9%) Share Price $240.97 Est. Cost/Share — Unrealized @ Report Date —
BMRN BioMarin Pharmaceutical Inc 1.1%
Value $20.52M (-53.6%) Shares 358,568 (-54.1%) Share Price $57.22 Est. Cost/Share — Unrealized @ Report Date —
PRAX Praxis Precision Medicines I 0.1%
Value $2.156M (-89.5%) Shares 6,440 (-89.9%) Share Price $334.79 Est. Cost/Share — Unrealized @ Report Date —
RARE Ultragenyx Pharmaceutical In 3.0%
Value $57.35M (-13.0%) Shares 1,717,505 (-45.4%) Share Price $33.39 Est. Cost/Share — Unrealized @ Report Date —
TYRA Tyra Biosciences Inc 0.1%
Value $1.031M (-86.8%) Shares 32,267 (-84.2%) Share Price $31.94 Est. Cost/Share — Unrealized @ Report Date —
RYTM Rhythm Pharmaceuticals Inc 2.3%
Value $45.3M (+15.7%) Shares 408,027 (-9.3%) Share Price $111.03 Est. Cost/Share — Unrealized @ Report Date —
DFTX Definium Therapeutics Inc 0.6%
Value $12.04M (+85.1%) Shares 255,903 (-25.6%) Share Price $47.04 Est. Cost/Share — Unrealized @ Report Date —
NKTR Nektar Therapeutics 1.7%
Value $32.93M (-10.2%) Shares 471,763 (-7.4%) Share Price $69.81 Est. Cost/Share — Unrealized @ Report Date —
AXSM Axsome Therapeutics Inc. 2.0%
Value $39.27M (+9.2%) Shares 160,429 (-24.6%) Share Price $244.77 Est. Cost/Share — Unrealized @ Report Date —
EWTX Edgewise Therapeutics Inc 0.8%
Value $15.48M (+27.1%) Shares 380,923 (-1.4%) Share Price $40.63 Est. Cost/Share — Unrealized @ Report Date —
IDYA IDEAYA Biosciences Inc 1.8%
Value $34.48M (-8.6%) Shares 925,119 (-18.3%) Share Price $37.27 Est. Cost/Share — Unrealized @ Report Date —
INBX Inhibrx Biosciences Inc 1.5%
Value $28.72M (+5.2%) Shares 303,103 (-25.3%) Share Price $94.75 Est. Cost/Share — Unrealized @ Report Date —

Unchanged Positions (13)

NTRA Natera Inc 21.8%
Value $421M Shares 1,550,280 Share Price $271.45 Est. Cost/Share — Unrealized @ Report Date —
AVBP Arrivent BioPharma Inc 3.0%
Value $58.95M Shares 1,696,752 Share Price $34.74 Est. Cost/Share — Unrealized @ Report Date —
RAPP Rapport Therapeutics Inc 4.1%
Value $79.36M Shares 1,904,408 Share Price $41.67 Est. Cost/Share — Unrealized @ Report Date —
BIOA BioAge Labs Inc 2.9%
Value $56.22M Shares 2,293,788 Share Price $24.51 Est. Cost/Share — Unrealized @ Report Date —
VERA Vera Therapeutics Inc 6.2%
Value $120M Shares 2,793,987 Share Price $42.91 Est. Cost/Share — Unrealized @ Report Date —
NXTC Nextcure Inc 0.0%
Value $356K Shares 222,654 Share Price $1.60 Est. Cost/Share — Unrealized @ Report Date —
JBIO Jade Biosciences Inc 0.1%
Value $2.386M Shares 107,391 Share Price $22.22 Est. Cost/Share — Unrealized @ Report Date —
MIRM Mirum Pharmaceuticals Inc 0.2%
Value $3.23M Shares 27,591 Share Price $117.07 Est. Cost/Share — Unrealized @ Report Date —
SEPN Septerna Inc 0.1%
Value $1.591M Shares 47,506 Share Price $33.49 Est. Cost/Share — Unrealized @ Report Date —
WVE Wave Life Sciences Ltd 0.1%
Value $1.1M Shares 189,253 Share Price $5.81 Est. Cost/Share — Unrealized @ Report Date —
SVRA Savara Inc 0.1%
Value $2.247M Shares 364,763 Share Price $6.16 Est. Cost/Share — Unrealized @ Report Date —
IMA ImageneBio Inc 0.0%
Value $188K Shares 31,884 Share Price $5.90 Est. Cost/Share — Unrealized @ Report Date —
BOLT Bolt Biotherapeutics Inc 0.0%
Value $530K Shares 137,721 Share Price $3.85 Est. Cost/Share — Unrealized @ Report Date —